1 Anti-Viral Cold And Flu Granule Market Overview
1.1 Product Overview and Scope of Anti-Viral Cold And Flu Granule
1.2 Anti-Viral Cold And Flu Granule Segment by Type
1.2.1 Global Anti-Viral Cold And Flu Granule Market Value Comparison by Type (2023-2029)
1.2.2 Children’s Edition
1.2.3 Adults’ Edition
1.3 Anti-Viral Cold And Flu Granule Segment by Sales Channel
1.3.1 Global Anti-Viral Cold And Flu Granule Market Value by Sales Channel: (2023-2029)
1.3.2 Retail Pharmacies
1.3.3 Hospital
1.3.4 Online Sales Platforms
1.4 Global Anti-Viral Cold And Flu Granule Market Size Estimates and Forecasts
1.4.1 Global Anti-Viral Cold And Flu Granule Revenue 2018-2029
1.4.2 Global Anti-Viral Cold And Flu Granule Sales 2018-2029
1.4.3 Global Anti-Viral Cold And Flu Granule Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Anti-Viral Cold And Flu Granule Market Competition by Manufacturers
2.1 Global Anti-Viral Cold And Flu Granule Sales Market Share by Manufacturers (2018-2023)
2.2 Global Anti-Viral Cold And Flu Granule Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Anti-Viral Cold And Flu Granule Average Price by Manufacturers (2018-2023)
2.4 Global Anti-Viral Cold And Flu Granule Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Anti-Viral Cold And Flu Granule, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Anti-Viral Cold And Flu Granule, Product Type & Application
2.7 Anti-Viral Cold And Flu Granule Market Competitive Situation and Trends
2.7.1 Anti-Viral Cold And Flu Granule Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Anti-Viral Cold And Flu Granule Players Market Share by Revenue
2.7.3 Global Anti-Viral Cold And Flu Granule Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Anti-Viral Cold And Flu Granule Retrospective Market Scenario by Region
3.1 Global Anti-Viral Cold And Flu Granule Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Anti-Viral Cold And Flu Granule Global Anti-Viral Cold And Flu Granule Sales by Region: 2018-2029
3.2.1 Global Anti-Viral Cold And Flu Granule Sales by Region: 2018-2023
3.2.2 Global Anti-Viral Cold And Flu Granule Sales by Region: 2024-2029
3.3 Global Anti-Viral Cold And Flu Granule Global Anti-Viral Cold And Flu Granule Revenue by Region: 2018-2029
3.3.1 Global Anti-Viral Cold And Flu Granule Revenue by Region: 2018-2023
3.3.2 Global Anti-Viral Cold And Flu Granule Revenue by Region: 2024-2029
3.4 North America Anti-Viral Cold And Flu Granule Market Facts & Figures by Country
3.4.1 North America Anti-Viral Cold And Flu Granule Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Anti-Viral Cold And Flu Granule Sales by Country (2018-2029)
3.4.3 North America Anti-Viral Cold And Flu Granule Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Anti-Viral Cold And Flu Granule Market Facts & Figures by Country
3.5.1 Europe Anti-Viral Cold And Flu Granule Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Anti-Viral Cold And Flu Granule Sales by Country (2018-2029)
3.5.3 Europe Anti-Viral Cold And Flu Granule Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anti-Viral Cold And Flu Granule Market Facts & Figures by Country
3.6.1 Asia Pacific Anti-Viral Cold And Flu Granule Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Anti-Viral Cold And Flu Granule Sales by Country (2018-2029)
3.6.3 Asia Pacific Anti-Viral Cold And Flu Granule Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Anti-Viral Cold And Flu Granule Market Facts & Figures by Country
3.7.1 Latin America Anti-Viral Cold And Flu Granule Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Anti-Viral Cold And Flu Granule Sales by Country (2018-2029)
3.7.3 Latin America Anti-Viral Cold And Flu Granule Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Anti-Viral Cold And Flu Granule Market Facts & Figures by Country
3.8.1 Middle East and Africa Anti-Viral Cold And Flu Granule Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Anti-Viral Cold And Flu Granule Sales by Country (2018-2029)
3.8.3 Middle East and Africa Anti-Viral Cold And Flu Granule Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Anti-Viral Cold And Flu Granule Sales by Type (2018-2029)
4.1.1 Global Anti-Viral Cold And Flu Granule Sales by Type (2018-2023)
4.1.2 Global Anti-Viral Cold And Flu Granule Sales by Type (2024-2029)
4.1.3 Global Anti-Viral Cold And Flu Granule Sales Market Share by Type (2018-2029)
4.2 Global Anti-Viral Cold And Flu Granule Revenue by Type (2018-2029)
4.2.1 Global Anti-Viral Cold And Flu Granule Revenue by Type (2018-2023)
4.2.2 Global Anti-Viral Cold And Flu Granule Revenue by Type (2024-2029)
4.2.3 Global Anti-Viral Cold And Flu Granule Revenue Market Share by Type (2018-2029)
4.3 Global Anti-Viral Cold And Flu Granule Price by Type (2018-2029)
5 Segment by Sales Channel
5.1 Global Anti-Viral Cold And Flu Granule Sales by Sales Channel (2018-2029)
5.1.1 Global Anti-Viral Cold And Flu Granule Sales by Sales Channel (2018-2023)
5.1.2 Global Anti-Viral Cold And Flu Granule Sales by Sales Channel (2024-2029)
5.1.3 Global Anti-Viral Cold And Flu Granule Sales Market Share by Sales Channel (2018-2029)
5.2 Global Anti-Viral Cold And Flu Granule Revenue by Sales Channel (2018-2029)
5.2.1 Global Anti-Viral Cold And Flu Granule Revenue by Sales Channel (2018-2023)
5.2.2 Global Anti-Viral Cold And Flu Granule Revenue by Sales Channel (2024-2029)
5.2.3 Global Anti-Viral Cold And Flu Granule Revenue Market Share by Sales Channel (2018-2029)
5.3 Global Anti-Viral Cold And Flu Granule Price by Sales Channel (2018-2029)
6 Key Companies Profiled
6.1 WELEDA
6.1.1 WELEDA Corporation Information
6.1.2 WELEDA Description and Business Overview
6.1.3 WELEDA Anti-Viral Cold And Flu Granule Sales, Revenue and Gross Margin (2018-2023)
6.1.4 WELEDA Anti-Viral Cold And Flu Granule Product Portfolio
6.1.5 WELEDA Recent Developments/Updates
6.2 Sichuan Everbright Pharmaceutical
6.2.1 Sichuan Everbright Pharmaceutical Corporation Information
6.2.2 Sichuan Everbright Pharmaceutical Description and Business Overview
6.2.3 Sichuan Everbright Pharmaceutical Anti-Viral Cold And Flu Granule Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Sichuan Everbright Pharmaceutical Anti-Viral Cold And Flu Granule Product Portfolio
6.2.5 Sichuan Everbright Pharmaceutical Recent Developments/Updates
6.3 Shandong Wohua Pharmaceutical
6.3.1 Shandong Wohua Pharmaceutical Corporation Information
6.3.2 Shandong Wohua Pharmaceutical Description and Business Overview
6.3.3 Shandong Wohua Pharmaceutical Anti-Viral Cold And Flu Granule Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Shandong Wohua Pharmaceutical Anti-Viral Cold And Flu Granule Product Portfolio
6.3.5 Shandong Wohua Pharmaceutical Recent Developments/Updates
6.4 Liaoning Xingao Pharmaceutical
6.4.1 Liaoning Xingao Pharmaceutical Corporation Information
6.4.2 Liaoning Xingao Pharmaceutical Description and Business Overview
6.4.3 Liaoning Xingao Pharmaceutical Anti-Viral Cold And Flu Granule Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Liaoning Xingao Pharmaceutical Anti-Viral Cold And Flu Granule Product Portfolio
6.4.5 Liaoning Xingao Pharmaceutical Recent Developments/Updates
6.5 Hubei Longda Medicine Technology
6.5.1 Hubei Longda Medicine Technology Corporation Information
6.5.2 Hubei Longda Medicine Technology Description and Business Overview
6.5.3 Hubei Longda Medicine Technology Anti-Viral Cold And Flu Granule Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Hubei Longda Medicine Technology Anti-Viral Cold And Flu Granule Product Portfolio
6.5.5 Hubei Longda Medicine Technology Recent Developments/Updates
6.6 Guangzhou Huacheng pharmaceutical plant
6.6.1 Guangzhou Huacheng pharmaceutical plant Corporation Information
6.6.2 Guangzhou Huacheng pharmaceutical plant Description and Business Overview
6.6.3 Guangzhou Huacheng pharmaceutical plant Anti-Viral Cold And Flu Granule Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Guangzhou Huacheng pharmaceutical plant Anti-Viral Cold And Flu Granule Product Portfolio
6.6.5 Guangzhou Huacheng pharmaceutical plant Recent Developments/Updates
6.7 Confidence
6.6.1 Confidence Corporation Information
6.6.2 Confidence Description and Business Overview
6.6.3 Confidence Anti-Viral Cold And Flu Granule Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Confidence Anti-Viral Cold And Flu Granule Product Portfolio
6.7.5 Confidence Recent Developments/Updates
6.8 Zhuhai AIA Pharmaceutical
6.8.1 Zhuhai AIA Pharmaceutical Corporation Information
6.8.2 Zhuhai AIA Pharmaceutical Description and Business Overview
6.8.3 Zhuhai AIA Pharmaceutical Anti-Viral Cold And Flu Granule Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Zhuhai AIA Pharmaceutical Anti-Viral Cold And Flu Granule Product Portfolio
6.8.5 Zhuhai AIA Pharmaceutical Recent Developments/Updates
6.9 Taihua Pharmacy
6.9.1 Taihua Pharmacy Corporation Information
6.9.2 Taihua Pharmacy Description and Business Overview
6.9.3 Taihua Pharmacy Anti-Viral Cold And Flu Granule Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Taihua Pharmacy Anti-Viral Cold And Flu Granule Product Portfolio
6.9.5 Taihua Pharmacy Recent Developments/Updates
6.10 Jiangsu Jurong Pharmaceutical
6.10.1 Jiangsu Jurong Pharmaceutical Corporation Information
6.10.2 Jiangsu Jurong Pharmaceutical Description and Business Overview
6.10.3 Jiangsu Jurong Pharmaceutical Anti-Viral Cold And Flu Granule Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Jiangsu Jurong Pharmaceutical Anti-Viral Cold And Flu Granule Product Portfolio
6.10.5 Jiangsu Jurong Pharmaceutical Recent Developments/Updates
6.11 Jiangsu Kanion Pharmaceutical
6.11.1 Jiangsu Kanion Pharmaceutical Corporation Information
6.11.2 Jiangsu Kanion Pharmaceutical Anti-Viral Cold And Flu Granule Description and Business Overview
6.11.3 Jiangsu Kanion Pharmaceutical Anti-Viral Cold And Flu Granule Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Jiangsu Kanion Pharmaceutical Anti-Viral Cold And Flu Granule Product Portfolio
6.11.5 Jiangsu Kanion Pharmaceutical Recent Developments/Updates
6.12 Laotongjun Pharmaceutical
6.12.1 Laotongjun Pharmaceutical Corporation Information
6.12.2 Laotongjun Pharmaceutical Anti-Viral Cold And Flu Granule Description and Business Overview
6.12.3 Laotongjun Pharmaceutical Anti-Viral Cold And Flu Granule Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Laotongjun Pharmaceutical Anti-Viral Cold And Flu Granule Product Portfolio
6.12.5 Laotongjun Pharmaceutical Recent Developments/Updates
6.13 Wuhan Jinpu Pharmaceutical
6.13.1 Wuhan Jinpu Pharmaceutical Corporation Information
6.13.2 Wuhan Jinpu Pharmaceutical Anti-Viral Cold And Flu Granule Description and Business Overview
6.13.3 Wuhan Jinpu Pharmaceutical Anti-Viral Cold And Flu Granule Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Wuhan Jinpu Pharmaceutical Anti-Viral Cold And Flu Granule Product Portfolio
6.13.5 Wuhan Jinpu Pharmaceutical Recent Developments/Updates
6.14 Jiangsu Xinxian Pharmaceutical
6.14.1 Jiangsu Xinxian Pharmaceutical Corporation Information
6.14.2 Jiangsu Xinxian Pharmaceutical Anti-Viral Cold And Flu Granule Description and Business Overview
6.14.3 Jiangsu Xinxian Pharmaceutical Anti-Viral Cold And Flu Granule Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Jiangsu Xinxian Pharmaceutical Anti-Viral Cold And Flu Granule Product Portfolio
6.14.5 Jiangsu Xinxian Pharmaceutical Recent Developments/Updates
6.15 Quetzal
6.15.1 Quetzal Corporation Information
6.15.2 Quetzal Anti-Viral Cold And Flu Granule Description and Business Overview
6.15.3 Quetzal Anti-Viral Cold And Flu Granule Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Quetzal Anti-Viral Cold And Flu Granule Product Portfolio
6.15.5 Quetzal Recent Developments/Updates
6.16 Kangxin Pharmaceutical
6.16.1 Kangxin Pharmaceutical Corporation Information
6.16.2 Kangxin Pharmaceutical Anti-Viral Cold And Flu Granule Description and Business Overview
6.16.3 Kangxin Pharmaceutical Anti-Viral Cold And Flu Granule Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Kangxin Pharmaceutical Anti-Viral Cold And Flu Granule Product Portfolio
6.16.5 Kangxin Pharmaceutical Recent Developments/Updates
6.17 SHANXI TAIHANG PHARMACEUTICAL
6.17.1 SHANXI TAIHANG PHARMACEUTICAL Corporation Information
6.17.2 SHANXI TAIHANG PHARMACEUTICAL Anti-Viral Cold And Flu Granule Description and Business Overview
6.17.3 SHANXI TAIHANG PHARMACEUTICAL Anti-Viral Cold And Flu Granule Sales, Revenue and Gross Margin (2018-2023)
6.17.4 SHANXI TAIHANG PHARMACEUTICAL Anti-Viral Cold And Flu Granule Product Portfolio
6.17.5 SHANXI TAIHANG PHARMACEUTICAL Recent Developments/Updates
6.18 Henan Tongyuan Pharmaceutical
6.18.1 Henan Tongyuan Pharmaceutical Corporation Information
6.18.2 Henan Tongyuan Pharmaceutical Anti-Viral Cold And Flu Granule Description and Business Overview
6.18.3 Henan Tongyuan Pharmaceutical Anti-Viral Cold And Flu Granule Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Henan Tongyuan Pharmaceutical Anti-Viral Cold And Flu Granule Product Portfolio
6.18.5 Henan Tongyuan Pharmaceutical Recent Developments/Updates
6.19 BAIHUI PHARMA
6.19.1 BAIHUI PHARMA Corporation Information
6.19.2 BAIHUI PHARMA Anti-Viral Cold And Flu Granule Description and Business Overview
6.19.3 BAIHUI PHARMA Anti-Viral Cold And Flu Granule Sales, Revenue and Gross Margin (2018-2023)
6.19.4 BAIHUI PHARMA Anti-Viral Cold And Flu Granule Product Portfolio
6.19.5 BAIHUI PHARMA Recent Developments/Updates
6.20 Xiangxue Pharmaceutical
6.20.1 Xiangxue Pharmaceutical Corporation Information
6.20.2 Xiangxue Pharmaceutical Anti-Viral Cold And Flu Granule Description and Business Overview
6.20.3 Xiangxue Pharmaceutical Anti-Viral Cold And Flu Granule Sales, Revenue and Gross Margin (2018-2023)
6.20.4 Xiangxue Pharmaceutical Anti-Viral Cold And Flu Granule Product Portfolio
6.20.5 Xiangxue Pharmaceutical Recent Developments/Updates
6.21 North Hulunbuir pharmaceutical limited company
6.21.1 North Hulunbuir pharmaceutical limited company Corporation Information
6.21.2 North Hulunbuir pharmaceutical limited company Anti-Viral Cold And Flu Granule Description and Business Overview
6.21.3 North Hulunbuir pharmaceutical limited company Anti-Viral Cold And Flu Granule Sales, Revenue and Gross Margin (2018-2023)
6.21.4 North Hulunbuir pharmaceutical limited company Anti-Viral Cold And Flu Granule Product Portfolio
6.21.5 North Hulunbuir pharmaceutical limited company Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti-Viral Cold And Flu Granule Industry Chain Analysis
7.2 Anti-Viral Cold And Flu Granule Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti-Viral Cold And Flu Granule Production Mode & Process
7.4 Anti-Viral Cold And Flu Granule Sales and Marketing
7.4.1 Anti-Viral Cold And Flu Granule Sales Channels
7.4.2 Anti-Viral Cold And Flu Granule Distributors
7.5 Anti-Viral Cold And Flu Granule Customers
8 Anti-Viral Cold And Flu Granule Market Dynamics
8.1 Anti-Viral Cold And Flu Granule Industry Trends
8.2 Anti-Viral Cold And Flu Granule Market Drivers
8.3 Anti-Viral Cold And Flu Granule Market Challenges
8.4 Anti-Viral Cold And Flu Granule Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Table 1. Global Anti-Viral Cold And Flu Granule Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Anti-Viral Cold And Flu Granule Market Value Comparison by Sales Channel (2023-2029) & (US$ Million)
Table 3. Global Anti-Viral Cold And Flu Granule Market Competitive Situation by Manufacturers in 2022
Table 4. Global Anti-Viral Cold And Flu Granule Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Anti-Viral Cold And Flu Granule Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Anti-Viral Cold And Flu Granule Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Anti-Viral Cold And Flu Granule Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Anti-Viral Cold And Flu Granule Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Anti-Viral Cold And Flu Granule, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Anti-Viral Cold And Flu Granule, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Anti-Viral Cold And Flu Granule, Product Type & Application
Table 12. Global Key Manufacturers of Anti-Viral Cold And Flu Granule, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Anti-Viral Cold And Flu Granule by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Viral Cold And Flu Granule as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Anti-Viral Cold And Flu Granule Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Anti-Viral Cold And Flu Granule Sales by Region (2018-2023) & (K Units)
Table 18. Global Anti-Viral Cold And Flu Granule Sales Market Share by Region (2018-2023)
Table 19. Global Anti-Viral Cold And Flu Granule Sales by Region (2024-2029) & (K Units)
Table 20. Global Anti-Viral Cold And Flu Granule Sales Market Share by Region (2024-2029)
Table 21. Global Anti-Viral Cold And Flu Granule Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Anti-Viral Cold And Flu Granule Revenue Market Share by Region (2018-2023)
Table 23. Global Anti-Viral Cold And Flu Granule Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Anti-Viral Cold And Flu Granule Revenue Market Share by Region (2024-2029)
Table 25. North America Anti-Viral Cold And Flu Granule Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Anti-Viral Cold And Flu Granule Sales by Country (2018-2023) & (K Units)
Table 27. North America Anti-Viral Cold And Flu Granule Sales by Country (2024-2029) & (K Units)
Table 28. North America Anti-Viral Cold And Flu Granule Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Anti-Viral Cold And Flu Granule Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Anti-Viral Cold And Flu Granule Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Anti-Viral Cold And Flu Granule Sales by Country (2018-2023) & (K Units)
Table 32. Europe Anti-Viral Cold And Flu Granule Sales by Country (2024-2029) & (K Units)
Table 33. Europe Anti-Viral Cold And Flu Granule Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Anti-Viral Cold And Flu Granule Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Anti-Viral Cold And Flu Granule Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Anti-Viral Cold And Flu Granule Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Anti-Viral Cold And Flu Granule Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Anti-Viral Cold And Flu Granule Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Anti-Viral Cold And Flu Granule Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Anti-Viral Cold And Flu Granule Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Anti-Viral Cold And Flu Granule Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Anti-Viral Cold And Flu Granule Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Anti-Viral Cold And Flu Granule Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Anti-Viral Cold And Flu Granule Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Anti-Viral Cold And Flu Granule Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Anti-Viral Cold And Flu Granule Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Anti-Viral Cold And Flu Granule Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Anti-Viral Cold And Flu Granule Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Anti-Viral Cold And Flu Granule Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Anti-Viral Cold And Flu Granule Sales (K Units) by Type (2018-2023)
Table 51. Global Anti-Viral Cold And Flu Granule Sales (K Units) by Type (2024-2029)
Table 52. Global Anti-Viral Cold And Flu Granule Sales Market Share by Type (2018-2023)
Table 53. Global Anti-Viral Cold And Flu Granule Sales Market Share by Type (2024-2029)
Table 54. Global Anti-Viral Cold And Flu Granule Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Anti-Viral Cold And Flu Granule Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Anti-Viral Cold And Flu Granule Revenue Market Share by Type (2018-2023)
Table 57. Global Anti-Viral Cold And Flu Granule Revenue Market Share by Type (2024-2029)
Table 58. Global Anti-Viral Cold And Flu Granule Price (US$/Unit) by Type (2018-2023)
Table 59. Global Anti-Viral Cold And Flu Granule Price (US$/Unit) by Type (2024-2029)
Table 60. Global Anti-Viral Cold And Flu Granule Sales (K Units) by Sales Channel (2018-2023)
Table 61. Global Anti-Viral Cold And Flu Granule Sales (K Units) by Sales Channel (2024-2029)
Table 62. Global Anti-Viral Cold And Flu Granule Sales Market Share by Sales Channel (2018-2023)
Table 63. Global Anti-Viral Cold And Flu Granule Sales Market Share by Sales Channel (2024-2029)
Table 64. Global Anti-Viral Cold And Flu Granule Revenue (US$ Million) by Sales Channel (2018-2023)
Table 65. Global Anti-Viral Cold And Flu Granule Revenue (US$ Million) by Sales Channel (2024-2029)
Table 66. Global Anti-Viral Cold And Flu Granule Revenue Market Share by Sales Channel (2018-2023)
Table 67. Global Anti-Viral Cold And Flu Granule Revenue Market Share by Sales Channel (2024-2029)
Table 68. Global Anti-Viral Cold And Flu Granule Price (US$/Unit) by Sales Channel (2018-2023)
Table 69. Global Anti-Viral Cold And Flu Granule Price (US$/Unit) by Sales Channel (2024-2029)
Table 70. WELEDA Corporation Information
Table 71. WELEDA Description and Business Overview
Table 72. WELEDA Anti-Viral Cold And Flu Granule Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. WELEDA Anti-Viral Cold And Flu Granule Product
Table 74. WELEDA Recent Developments/Updates
Table 75. Sichuan Everbright Pharmaceutical Corporation Information
Table 76. Sichuan Everbright Pharmaceutical Description and Business Overview
Table 77. Sichuan Everbright Pharmaceutical Anti-Viral Cold And Flu Granule Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Sichuan Everbright Pharmaceutical Anti-Viral Cold And Flu Granule Product
Table 79. Sichuan Everbright Pharmaceutical Recent Developments/Updates
Table 80. Shandong Wohua Pharmaceutical Corporation Information
Table 81. Shandong Wohua Pharmaceutical Description and Business Overview
Table 82. Shandong Wohua Pharmaceutical Anti-Viral Cold And Flu Granule Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Shandong Wohua Pharmaceutical Anti-Viral Cold And Flu Granule Product
Table 84. Shandong Wohua Pharmaceutical Recent Developments/Updates
Table 85. Liaoning Xingao Pharmaceutical Corporation Information
Table 86. Liaoning Xingao Pharmaceutical Description and Business Overview
Table 87. Liaoning Xingao Pharmaceutical Anti-Viral Cold And Flu Granule Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Liaoning Xingao Pharmaceutical Anti-Viral Cold And Flu Granule Product
Table 89. Liaoning Xingao Pharmaceutical Recent Developments/Updates
Table 90. Hubei Longda Medicine Technology Corporation Information
Table 91. Hubei Longda Medicine Technology Description and Business Overview
Table 92. Hubei Longda Medicine Technology Anti-Viral Cold And Flu Granule Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Hubei Longda Medicine Technology Anti-Viral Cold And Flu Granule Product
Table 94. Hubei Longda Medicine Technology Recent Developments/Updates
Table 95. Guangzhou Huacheng pharmaceutical plant Corporation Information
Table 96. Guangzhou Huacheng pharmaceutical plant Description and Business Overview
Table 97. Guangzhou Huacheng pharmaceutical plant Anti-Viral Cold And Flu Granule Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Guangzhou Huacheng pharmaceutical plant Anti-Viral Cold And Flu Granule Product
Table 99. Guangzhou Huacheng pharmaceutical plant Recent Developments/Updates
Table 100. Confidence Corporation Information
Table 101. Confidence Description and Business Overview
Table 102. Confidence Anti-Viral Cold And Flu Granule Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Confidence Anti-Viral Cold And Flu Granule Product
Table 104. Confidence Recent Developments/Updates
Table 105. Zhuhai AIA Pharmaceutical Corporation Information
Table 106. Zhuhai AIA Pharmaceutical Description and Business Overview
Table 107. Zhuhai AIA Pharmaceutical Anti-Viral Cold And Flu Granule Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Zhuhai AIA Pharmaceutical Anti-Viral Cold And Flu Granule Product
Table 109. Zhuhai AIA Pharmaceutical Recent Developments/Updates
Table 110. Taihua Pharmacy Corporation Information
Table 111. Taihua Pharmacy Description and Business Overview
Table 112. Taihua Pharmacy Anti-Viral Cold And Flu Granule Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Taihua Pharmacy Anti-Viral Cold And Flu Granule Product
Table 114. Taihua Pharmacy Recent Developments/Updates
Table 115. Jiangsu Jurong Pharmaceutical Corporation Information
Table 116. Jiangsu Jurong Pharmaceutical Description and Business Overview
Table 117. Jiangsu Jurong Pharmaceutical Anti-Viral Cold And Flu Granule Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Jiangsu Jurong Pharmaceutical Anti-Viral Cold And Flu Granule Product
Table 119. Jiangsu Jurong Pharmaceutical Recent Developments/Updates
Table 120. Jiangsu Kanion Pharmaceutical Corporation Information
Table 121. Jiangsu Kanion Pharmaceutical Description and Business Overview
Table 122. Jiangsu Kanion Pharmaceutical Anti-Viral Cold And Flu Granule Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Jiangsu Kanion Pharmaceutical Anti-Viral Cold And Flu Granule Product
Table 124. Jiangsu Kanion Pharmaceutical Recent Developments/Updates
Table 125. Laotongjun Pharmaceutical Corporation Information
Table 126. Laotongjun Pharmaceutical Description and Business Overview
Table 127. Laotongjun Pharmaceutical Anti-Viral Cold And Flu Granule Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Laotongjun Pharmaceutical Anti-Viral Cold And Flu Granule Product
Table 129. Laotongjun Pharmaceutical Recent Developments/Updates
Table 130. Wuhan Jinpu Pharmaceutical Corporation Information
Table 131. Wuhan Jinpu Pharmaceutical Description and Business Overview
Table 132. Wuhan Jinpu Pharmaceutical Anti-Viral Cold And Flu Granule Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Wuhan Jinpu Pharmaceutical Anti-Viral Cold And Flu Granule Product
Table 134. Wuhan Jinpu Pharmaceutical Recent Developments/Updates
Table 135. Jiangsu Xinxian Pharmaceutical Corporation Information
Table 136. Jiangsu Xinxian Pharmaceutical Description and Business Overview
Table 137. Jiangsu Xinxian Pharmaceutical Anti-Viral Cold And Flu Granule Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Jiangsu Xinxian Pharmaceutical Anti-Viral Cold And Flu Granule Product
Table 139. Jiangsu Xinxian Pharmaceutical Recent Developments/Updates
Table 140. Quetzal Corporation Information
Table 141. Quetzal Description and Business Overview
Table 142. Quetzal Anti-Viral Cold And Flu Granule Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Quetzal Anti-Viral Cold And Flu Granule Product
Table 144. Quetzal Recent Developments/Updates
Table 145. Kangxin Pharmaceutical Corporation Information
Table 146. Kangxin Pharmaceutical Description and Business Overview
Table 147. Kangxin Pharmaceutical Anti-Viral Cold And Flu Granule Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. Kangxin Pharmaceutical Anti-Viral Cold And Flu Granule Product
Table 149. Kangxin Pharmaceutical Recent Developments/Updates
Table 150. SHANXI TAIHANG PHARMACEUTICAL Corporation Information
Table 151. SHANXI TAIHANG PHARMACEUTICAL Description and Business Overview
Table 152. SHANXI TAIHANG PHARMACEUTICAL Anti-Viral Cold And Flu Granule Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 153. SHANXI TAIHANG PHARMACEUTICAL Anti-Viral Cold And Flu Granule Product
Table 154. SHANXI TAIHANG PHARMACEUTICAL Recent Developments/Updates
Table 155. Henan Tongyuan Pharmaceutical Corporation Information
Table 156. Henan Tongyuan Pharmaceutical Description and Business Overview
Table 157. Henan Tongyuan Pharmaceutical Anti-Viral Cold And Flu Granule Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 158. Henan Tongyuan Pharmaceutical Anti-Viral Cold And Flu Granule Product
Table 159. Henan Tongyuan Pharmaceutical Recent Developments/Updates
Table 160. BAIHUI PHARMA Corporation Information
Table 161. BAIHUI PHARMA Description and Business Overview
Table 162. BAIHUI PHARMA Anti-Viral Cold And Flu Granule Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 163. BAIHUI PHARMA Anti-Viral Cold And Flu Granule Product
Table 164. BAIHUI PHARMA Recent Developments/Updates
Table 165. Xiangxue Pharmaceutical Corporation Information
Table 166. Xiangxue Pharmaceutical Description and Business Overview
Table 167. Xiangxue Pharmaceutical Anti-Viral Cold And Flu Granule Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 168. Xiangxue Pharmaceutical Anti-Viral Cold And Flu Granule Product
Table 169. Xiangxue Pharmaceutical Recent Developments/Updates
Table 170. North Hulunbuir pharmaceutical limited company Corporation Information
Table 171. North Hulunbuir pharmaceutical limited company Description and Business Overview
Table 172. North Hulunbuir pharmaceutical limited company Anti-Viral Cold And Flu Granule Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 173. North Hulunbuir pharmaceutical limited company Anti-Viral Cold And Flu Granule Product
Table 174. North Hulunbuir pharmaceutical limited company Recent Developments/Updates
Table 175. Key Raw Materials Lists
Table 176. Raw Materials Key Suppliers Lists
Table 177. Anti-Viral Cold And Flu Granule Distributors List
Table 178. Anti-Viral Cold And Flu Granule Customers List
Table 179. Anti-Viral Cold And Flu Granule Market Trends
Table 180. Anti-Viral Cold And Flu Granule Market Drivers
Table 181. Anti-Viral Cold And Flu Granule Market Challenges
Table 182. Anti-Viral Cold And Flu Granule Market Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Anti-Viral Cold And Flu Granule
Figure 2. Global Anti-Viral Cold And Flu Granule Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Anti-Viral Cold And Flu Granule Market Share by Type in 2022 & 2029
Figure 4. Children's Edition Product Picture
Figure 5. Adults' Edition Product Picture
Figure 6. Global Anti-Viral Cold And Flu Granule Market Value Comparison by Sales Channel (2023-2029) & (US$ Million)
Figure 7. Global Anti-Viral Cold And Flu Granule Market Share by Sales Channel in 2022 & 2029
Figure 8. Retail Pharmacies
Figure 9. Hospital
Figure 10. Online Sales Platforms
Figure 11. Global Anti-Viral Cold And Flu Granule Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Anti-Viral Cold And Flu Granule Market Size (2018-2029) & (US$ Million)
Figure 13. Global Anti-Viral Cold And Flu Granule Sales (2018-2029) & (K Units)
Figure 14. Global Anti-Viral Cold And Flu Granule Average Price (US$/Unit) & (2018-2029)
Figure 15. Anti-Viral Cold And Flu Granule Report Years Considered
Figure 16. Anti-Viral Cold And Flu Granule Sales Share by Manufacturers in 2022
Figure 17. Global Anti-Viral Cold And Flu Granule Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Anti-Viral Cold And Flu Granule Players: Market Share by Revenue in 2022
Figure 19. Anti-Viral Cold And Flu Granule Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Anti-Viral Cold And Flu Granule Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Anti-Viral Cold And Flu Granule Sales Market Share by Country (2018-2029)
Figure 22. North America Anti-Viral Cold And Flu Granule Revenue Market Share by Country (2018-2029)
Figure 23. United States Anti-Viral Cold And Flu Granule Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Anti-Viral Cold And Flu Granule Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Anti-Viral Cold And Flu Granule Sales Market Share by Country (2018-2029)
Figure 26. Europe Anti-Viral Cold And Flu Granule Revenue Market Share by Country (2018-2029)
Figure 27. Germany Anti-Viral Cold And Flu Granule Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Anti-Viral Cold And Flu Granule Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Anti-Viral Cold And Flu Granule Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Anti-Viral Cold And Flu Granule Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Anti-Viral Cold And Flu Granule Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Anti-Viral Cold And Flu Granule Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Anti-Viral Cold And Flu Granule Revenue Market Share by Region (2018-2029)
Figure 34. China Anti-Viral Cold And Flu Granule Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Anti-Viral Cold And Flu Granule Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Anti-Viral Cold And Flu Granule Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Anti-Viral Cold And Flu Granule Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Anti-Viral Cold And Flu Granule Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan Anti-Viral Cold And Flu Granule Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Indonesia Anti-Viral Cold And Flu Granule Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Thailand Anti-Viral Cold And Flu Granule Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Malaysia Anti-Viral Cold And Flu Granule Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Latin America Anti-Viral Cold And Flu Granule Sales Market Share by Country (2018-2029)
Figure 44. Latin America Anti-Viral Cold And Flu Granule Revenue Market Share by Country (2018-2029)
Figure 45. Mexico Anti-Viral Cold And Flu Granule Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Brazil Anti-Viral Cold And Flu Granule Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Argentina Anti-Viral Cold And Flu Granule Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Colombia Anti-Viral Cold And Flu Granule Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa Anti-Viral Cold And Flu Granule Sales Market Share by Country (2018-2029)
Figure 50. Middle East & Africa Anti-Viral Cold And Flu Granule Revenue Market Share by Country (2018-2029)
Figure 51. Turkey Anti-Viral Cold And Flu Granule Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Anti-Viral Cold And Flu Granule Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. UAE Anti-Viral Cold And Flu Granule Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Global Sales Market Share of Anti-Viral Cold And Flu Granule by Type (2018-2029)
Figure 55. Global Revenue Market Share of Anti-Viral Cold And Flu Granule by Type (2018-2029)
Figure 56. Global Anti-Viral Cold And Flu Granule Price (US$/Unit) by Type (2018-2029)
Figure 57. Global Sales Market Share of Anti-Viral Cold And Flu Granule by Sales Channel (2018-2029)
Figure 58. Global Revenue Market Share of Anti-Viral Cold And Flu Granule by Sales Channel (2018-2029)
Figure 59. Global Anti-Viral Cold And Flu Granule Price (US$/Unit) by Sales Channel (2018-2029)
Figure 60. Anti-Viral Cold And Flu Granule Value Chain
Figure 61. Anti-Viral Cold And Flu Granule Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
